News about "Abbott "

Abbott Receives FDA Approval for CardioMEMS Patient App Updates

Abbott receives FDA approval for CardioMEMS HF System updates that enable eligible patients to view pulmonary artery pressure readings through the CardioGuide HF App.

Abbott | 07/10/2026 | By News Bureau

Abbott Launches FDA-Approved Blood Test for Colorectal Cancer Screening

Abbott launches SimpleScreen CRC in the US, adding an FDA-approved blood-based colorectal cancer screening option to its diagnostics portfolio.

Abbott | 03/10/2026 | By News Bureau

Abbott Receives CE Mark for Next-Generation Amulet 360 Device for Stroke Prevention in AFib

Abbott’s Amulet 360 LAA Occluder has received CE Mark approval in Europe, expanding options for minimally invasive stroke prevention among patients with non-valvular atrial fibrillation.

Abbott | 31/08/2026 | By News Bureau |  122

Abbott Secures CE Mark for World's First Dual Glucose and Ketone Monitoring System for Diabetes Management

Abbott has received CE Mark approval for Libre Duo, the world’s first dual glucose-ketone sensing technology, offering continuous monitoring of both glucose and ketone levels to help prevent diabetic ketoacidosis and support safer diabetes care.

Abbott | 30/05/2026 | By News Bureau |  134

Late-breaking Data Highlight Positive Safety and Closure Rates for Abbott's New Stroke-prevention Device in non-Valvular AFib

Abbott has reported positive late-breaking data from the VERITAS Study showing its Amulet 360 Left Atrial Appendage Occluder met safety and effectiveness endpoints, supporting its potential to reduce stroke risk in patients with non-valvular atrial fibrillation.

Abbott | 09/02/2026 | By News Bureau |  279

Abbott Secures CE Mark for TactiFlex Duo Ablation Catheter to Treat Atrial Fibrillation in Europe

Abbott has received CE Mark approval for its TactiFlex Duo Ablation Catheter, enabling dual-energy AFib treatment in Europe and marking successful first commercial procedures across the EU.

Abbott | 21/01/2026 | By News Bureau |  305

Abbott Secures FDA Clearance and CE Nod for Amplatzer Piccolo Heart Device

Abbott has received US FDA clearance and CE Mark for its Amplatzer Piccolo Delivery System, the first device specifically designed to treat premature infants with Patent Ductus Arteriosus (PDA). The system enables precise placement of the Amplatzer Piccolo Occluder in infants, addressing a condition that affects around 20 percent of premature infants.

Abbott | 19/12/2025 | By News Bureau |  196

Abbott Issues Medical Device Correction for FreeStyle Libre 3 Sensors

Abbott has initiated a medical device correction in the United States for specific batches of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors after internal testing found that some units may deliver inaccurate low glucose readings.

Abbott | 26/11/2025 | By Darshana |  425

Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors

After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.

Abbott | 21/11/2025 | By Dineshwori |  281

Abbott Launches World?s First Dual-Chamber Leadless Pacemaker System in India

Abbott launches the world’s first AVEIR dual-chamber leadless pacemaker in India, enabling proper heart rhythm without wires or surgical pockets.

Abbott | 06/10/2025 | By Dineshwori